|
Roldán V, Arroyo AB, Salloum-Asfar S, Manzano-Fernández S, García-Barberá N, Marín F, Vicente V, González-Conejero R, Martínez C. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation. Thromb Haemost. 2014 Oct;112(4):781-8. doi: 10.1160/TH14-01-0092. PubMed PMID: 25008481.
AÑO: 2014; IF: 4.984
|
25008481
|
Orenes-Piñero E, Pineda J, Roldán V, Hernández-Romero D, Marco P, Tello-Montoliu A, Sogorb F, Valdés M, Lip GY, Marín F. Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State. J Atheroscler Thromb. 2015;22(6):610-7. doi: 10.5551/jat.26161. PubMed PMID: 25737193.
AÑO: 2015; IF: 2.411
|
|
Manzano-Fernández S, Andreu-Cayuelas JM, Marín F, Orenes-Piñero E, Gallego P, Valdés M, Vicente V, Lip GY, Roldán V. Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation. Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):497-504. doi: 10.1016/j.rec.2014.06.026. PubMed PMID: 25457087.
AÑO: 2015; IF: 4.596
|
|
Roldán V, Marín F. The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists. Thromb Haemost. 2015 Apr;113(4):671-3. doi: 10.1160/TH14-12-1087. PubMed PMID: 25673326.
AÑO: 2015; IF: 5.255
|
|
Marín F, Roldán V. Biomarkers: GDF-15 and risk stratification in atrial fibrillation. Nat Rev Cardiol. 2015 Jan;12(1):8-9. doi: 10.1038/nrcardio.2014.190. Review. PubMed PMID: 25421166.
AÑO: 2015; IF: 49.421
|